Robyn Hunter

CIK: 0001713932

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TENX

TENAX THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

TENX
TENAX THERAPEUTICS, INC.
Jan 9, 2026
Award(A)
Stock Option (right to buy)
Direct
30K shares-
TENX
TENAX THERAPEUTICS, INC.
Jul 1, 2025
Award(A)
Stock Option (right to buy)
Direct
80K shares-
TENX
TENAX THERAPEUTICS, INC.
Dec 10, 2024
Award(A)
Stock Option (right to buy)
Direct
100K shares-

		Type	Shares	Price		Ownership
Jan 9, 2026	TENX TENAX THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jul 1, 2025	TENX TENAX THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	80,000	-	-	Direct
Dec 10, 2024	TENX TENAX THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	100,000	-	-	Direct

1-3 of 3 transactions

About Hunter Robyn

Hunter Robyn (SEC CIK 0001713932) files insider reports with the SEC as Director of TENAX THERAPEUTICS, INC. (TENX).

Signal8 holds 3 ownership filings by Hunter Robyn, all Form 4s, filed between Dec 12, 2024 and Jan 13, 2026. Those filings report 3 transactions, from Dec 10, 2024 to Jan 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hunter Robyn's filings is in CHAPEL HILL, NC.

Recent filings by Hunter Robyn

Jan 9, 2026: Grant or award of TENX derivative securities (Form 4, code A).
Jul 1, 2025: Grant or award of TENX derivative securities (Form 4, code A).
Dec 10, 2024: Grant or award of TENX derivative securities (Form 4, code A).

Other insiders filing for TENAX THERAPEUTICS, INC. (TENX)

ADAR1 Capital Management, LLC, 10% Owner
Doogan Declan, Director
Giordano Christopher Thomas, CEO
STAAB THOMAS R II, Chief Financial Officer
MCGAULEY THOMAS, Interim CFO
Davidson Michael H., Director

How to read Form 4 transaction codes